Assessing Quality of Life in Clinical Trials: Methods and Practice

Front Cover
Oxford University Press, 2005 - Medical - 467 pages
1 Review
Researchers in all clinical fields are fully aware of the importance of Quality of Life measurements in judging the efficacy of a given treatment. Psychological criteria play an important role in this evaluation. Assessment of Quality of Life in Clinical Trials: methods and practice explores the current state of the art and illustrates the benefits and potential of health related quality of life assessment in clinical trials. It covers a wide range of analytical issues, emphasizing new and innovative approaches that are of practical and clinical importance.
 

What people are saying - Write a review

User Review - Flag as inappropriate

13 sre

Contents

Generic versus diseasetargeted instruments
3
Developing questionnaires
9
Reliability and validity including responsiveness
25
Evaluating multiitem scales
41
Applying item response theory modelling for evaluating questionnaire item and scale properties
55
Adapting and using questionnaires
75
Translating and evaluating questionnaires cultural issues for international research
77
Computerized adaptive testing and item banking
95
Individualized quality of life
225
Meaningful differences
243
Healthrelated quality of life outcomes in clinical trials
259
Response shift you know its there but how do you capture it? Challenges for the next phase of research
275
Individual patient monitoring
291
Measures for clinical trials
307
Selfrated health
309
Generic adult health status measures
325

Developing a questionnaire using item response theory a case study of fatigue
113
Context effects and proxy assessments
131
Analysis
147
Analysing longitudinal studies of QoL
149
Preventing missing data
167
Analysing studies with missing data
179
The role and use of differential item functioning DIF analysis of quality of life data from clinical trials
195
Reporting analyses from clinical trials
209
Interpreting QoL in individuals and groups
223
Practical considerations in the measurement of HRQoL in childadolescent clinical trials
339
Developing diseasetargeted HRQoL measures for neurologic conditions
369
Beyond clinical trials
389
Values and valuation in the measurement of HRQoL
391
Preferencebased measures utility and qualityadjusted life years
405
Discrete choice experiments
431
Combining clinical trials metaanalyses
447
Index
461
Copyright

Common terms and phrases

About the author (2005)

Peter Fayers is at Department of Public Health, Aberdeen Medical School, Aberdeen, UK. Ron Hays is at UCLA School of Medicine, Division of GIM and Health Services Research, UCLA, Los Angeles, USA.

Bibliographic information